Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany

Longitudinal data on the E6/E7 mRNA-based Aptima human papillomavirus (AHPV) assay exceeding three years in comparison to the gold standard Digene Hybrid Capture 2 (HC2) test are not available. We previously reported the cross-sectional data of the German AHPV Screening Trial (GAST) in which 10,040...

Descripción completa

Detalles Bibliográficos
Autores principales: Iftner, Thomas, Neis, Klaus-Joachim, Castanon, Alejandra, Landy, Rebecca, Holz, Barbara, Woll-Herrmann, Astrid, Iftner, Angelika, Staebler, Annette, Wallwiener, Diethelm, Hann von Weyhern, Claus, Neis, Felix, Haedicke-Jarboui, Juliane, Martus, Peter, Brucker, Sara, Henes, Melanie, Sasieni, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Virology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322477/
https://www.ncbi.nlm.nih.gov/pubmed/30355760
http://dx.doi.org/10.1128/JCM.01177-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322477/
https://www.ncbi.nlm.nih.gov/pubmed/30355760
http://dx.doi.org/10.1128/JCM.01177-18

Ejemplares similares